| Dr Jennifer Linh Mcosker, MD | |
|
315 S Manning Blvd, Medical Imaging, Albany, NY 12208-1707 | |
| (518) 525-1550 | |
| Not Available |
| Full Name | Dr Jennifer Linh Mcosker |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 315 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184948747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 274571 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Hospital | Troy, NY | Hospital |
| St Peter's Hospital | Albany, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Peter's Health Partners Medical Associates, P.c. | 6103061189 | 393 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
| Entity Name | New York Oncology Hematology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609863448 PECOS PAC ID: 3072406222 Enrollment ID: O20040203000652 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
| Entity Name | Northeast Medical Imaging Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396720140 PECOS PAC ID: 1153310727 Enrollment ID: O20040510000121 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
| Entity Name | Albany Advanced Imaging Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871578898 PECOS PAC ID: 1153308820 Enrollment ID: O20040630000901 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Linh Mcosker, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Dr Jennifer Linh Mcosker, MD 315 S Manning Blvd, Medical Imaging, Albany, NY 12208-1707 Ph: (518) 525-1550 |
News Archive
Labopharm Inc. today announced it has received notice from Sun Pharma Global FZE advising that Sun has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 100, 200 and 300 mg generic versions of Ryzolt(TM) (tramadol hydrochloride extended-release 100, 200 and 300 mg tablets) in the United States.
As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Results from a study published online in the Journal of Pediatrics hold the potential to substantially improve clinical decision-making to determine when a premature newborn is ready for oral feeding. The study describes developmental salivary biomarkers associated with feeding success in newborns, markers that could lead to development of objective assessment tools for caregivers.
› Verified 3 days ago
Robert A Belgam, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Stratton Va Medical Center, Albany, NY 12208 Phone: 518-626-6650 Fax: 518-626-6644 | |
Mr. Sreenivas Garla, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Radiology Dept, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
David Jahangir, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 | |
Dr. S Rao Aravapalli, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Dept. Of Radiology, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
Sean Peter Roddy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany, NY 12208 Phone: 518-262-5640 Fax: 518-262-9413 | |
Dena Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 | |
Matthew Robert Shalvoy, MD Radiology Medicare: Medicare Enrolled Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 Fax: 518-525-1200 |